Inventor
Brian T. Hopkins
Inventor
Newton, MA, US
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Dprimary
C07DHeterocyclic compounds32%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes25%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium7%
C07BGeneral methods of organic chemistry6%
A01NPreservation of bodies of humans or animals or plants or parts thereof1%
G01NInvestigating or analysing materials by determining their chemical or physical properties1%
PatentTitleYear
10,961,237Inhibiting agents for Bruton's tyrosine kinase202110,899,753Inhibiting agents for Bruton's tyrosine kinase202110,759,783Biaryl inhibitors of Bruton'S tyrosine kinase202010,618,887Pyrimidinyl tyrosine kinase inhibitors202010,577,374Bruton's tyrosine kinase inhibitors202010,280,169Biaryl bruton's tyrosine kinase inhibitors201910,227,341Inhibiting agents for bruton's tyrosine kinase201910,189,817Inhibitors of Bruton's tyrosine kinase201910,189,829Inhibiting agents for Bruton's tyrosine kinase201910,081,619Biaryl inhibitors of bruton's tyrosine kinase20189,944,622Pyrimidinyl tyrosine kinase inhibitors20189,809,577'Biaryl inhibitors of Bruton\'s tyrosine kinase'20179,790,229'Bruton\'s tyrosine kinase inhibitors'20179,394,277'Pyrimidinyl tyrosine kinase inhibitors'20169,353,087'Inhibitors of Bruton\'s tyrosine kinase'20169,273,028'Heterocyclic tyrosine kinase inhibitors'20169,249,146'Bruton\'S tyrosine kinase inhibitors'20169,198,420'Rodenticidal norbormide analogues'20159,029,359'Heteroaryl Btk inhibitors'20158,785,440'Bruton\'s tyrosine kinase inhibitors'20148,609,706'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20138,461,191'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20138,304,428'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20128,178,690'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20127,928,244'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20117,851,637'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20107,842,815'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'20107,745,464'Compounds and methods for inhibiting the interaction of BCL proteins with binding partners'2010Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2010–2016Patents assigned to HOPKINS BRIAN T (8)· patent assignee history
2010–2013Patents assigned to CASTRO ALFREDO C (5)· patent assignee history
2010Based in Brookline, MA, US· patent location history
2011–2021Based in Newton, MA, US· patent location history
2014–2020Patents assigned to SUNESIS PHARMACEUTICALS INC (11)· patent assignee history
2014–2016Patents assigned to BIOGEN IDEC INC (5)· patent assignee history
2015Based in Lincoln, NZ· patent location history
2016–2021Patents assigned to BIOGEN MA INC (17)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BIOGEN MA INC | 17 | 2016–2021 |
| SUNESIS PHARMACEUTICALS INC | 11 | 2014–2020 |
| HOPKINS BRIAN Tself | 8 | 2010–2016 |
| BIOGEN IDEC INC | 5 | 2014–2016 |
| CASTRO ALFREDO C | 5 | 2010–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Newton, Massachusetts, US | 24 | 2011–2021 |
| Brookline, Massachusetts, US | 3 | 2010 |
| Lincoln, NZ | 1 | 2015 |